13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001892134-26-000001
Total Value
$3.72B
Positions
40
Other Managers
0
Confidential Omitted
No
Holdings (40)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 16,943,774 | $594.4M | 15.96% |
| 2 | MIRUM PHARMACEUTICALS INC | MIRM | 6,795,121 | $536.7M | 14.42% |
| 3 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 9,874,511 | $286.8M | 7.70% |
| 4 | BRIDGEBIO PHARMA INC | BBIO | 3,545,557 | $271.2M | 7.28% |
| 5 | MBX BIOSCIENCES INC | MBX | 6,652,013 | $209.8M | 5.64% |
| 6 | PHATHOM PHARMACEUTICALS INC | PHAT | 12,466,489 | $206.8M | 5.55% |
| 7 | MAZE THERAPEUTICS INC | MAZE | 4,567,274 | $189.2M | 5.08% |
| 8 | TREVI THERAPEUTICS INC | TRVI | 10,259,409 | $128.4M | 3.45% |
| 9 | KRYSTAL BIOTECH INC | KRYS | 488,460 | $120.4M | 3.23% |
| 10 | DISC MEDICINE INC | IRON | 1,260,000 | $100.1M | 2.69% |
| 11 | ERASCA INC | ERAS | 22,729,436 | $84.6M | 2.27% |
| 12 | KALVISTA PHARMACEUTICALS INC | KALV | 5,039,867 | $81.4M | 2.19% |
| 13 | PALVELLA THERAPEUTICS INC NE | PVLA | 722,400 | $75.6M | 2.03% |
| 14 | AVIDITY BIOSCIENCES INC | 05370A108 | 983,125 | $70.9M | 1.90% |
| 15 | REVOLUTION MEDICINES INC | RVMDW | 797,455 | $63.5M | 1.71% |
| 16 | DYNE THERAPEUTICS INC | DYN | 3,153,082 | $61.7M | 1.66% |
| 17 | TARSUS PHARMACEUTICALS INC | TARS | 728,644 | $59.7M | 1.60% |
| 18 | SAVARA INC | SVRA | 9,862,301 | $59.5M | 1.60% |
| 19 | CYTOKINETICS INC | CYTK | 934,642 | $59.4M | 1.60% |
| 20 | ABIVAX SA | AAVXF | 378,300 | $51.0M | 1.37% |
| 21 | LEXEO THERAPEUTICS INC | LXEO | 4,424,725 | $43.9M | 1.18% |
| 22 | AGIOS PHARMACEUTICALS INC | AGIO | 1,279,754 | $34.8M | 0.94% |
| 23 | ACADIA PHARMACEUTICALS INC | ACAD | 1,297,198 | $34.6M | 0.93% |
| 24 | ZAI LAB LTD | ZLAB | 1,902,320 | $33.6M | 0.90% |
| 25 | RAPT THERAPEUTICS INC | 75382E208 | 983,333 | $33.3M | 0.89% |
| 26 | VOR BIOPHARMA INC | VOR | 2,543,939 | $33.3M | 0.89% |
| 27 | ASCENDIS PHARMA A/S | ASND | 133,333 | $28.4M | 0.76% |
| 28 | AURA BIOSCIENCES INC | AURA | 5,100,000 | $27.8M | 0.75% |
| 29 | MANNKIND CORP | MNKD | 4,225,000 | $24.0M | 0.64% |
| 30 | VALNEVA SE | VALN | 2,291,666 | $20.2M | 0.54% |
| 31 | ALKERMES PLC | ALKS | 700,647 | $19.6M | 0.53% |
| 32 | EVOLUS INC | EOLS | 2,630,665 | $17.5M | 0.47% |
| 33 | IMMUNOCORE HLDGS PLC | IMCR | 384,782 | $13.4M | 0.36% |
| 34 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $11.5M | 0.31% |
| 35 | TRAVERE THERAPEUTICS INC | TVTX | 241,592 | $9.2M | 0.25% |
| 36 | AUTOLUS THERAPEUTICS PLC | AUTL | 4,623,324 | $9.2M | 0.25% |
| 37 | ALLOGENE THERAPEUTICS INC | ALLO | 3,868,750 | $5.3M | 0.14% |
| 38 | DESIGN THERAPEUTICS INC | DSGN | 521,000 | $4.9M | 0.13% |
| 39 | XILIO THERAPEUTICS INC | XLO | 5,915,091 | $3.8M | 0.10% |
| 40 | IBIO INC | IBIO | 1,953,467 | $3.8M | 0.10% |